A review of HER2 overexpression and somatic mutations in cancers.

Abstract excerpt

The Human Epidermal Growth Factor Receptor (HER) proteins family, which includes HER2, are membrane-bound receptors that activate many intracellular pathways associated with growth and development. When there are mutations in HER2, or when it becomes overexpressed, it can cause oncogenesis and offer differential prognosis and treatment across almost all cancer types. Both mutations in HER2 and its overexpression...

Topics

Join the communities discussing this publication.

• Breast Neoplasms
• Carcinogenesis
• HER2/EGFR in Cancer Research
• Monoclonal and Polyclonal Antibodies Research
• Mutation